The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Byrd Scott A. since 2011.
The trader's CIK number is 1466916.
At the time of the last reporting, Byrd Scott A. was the SVP, Chief Commercial Officer of Cadence Pharmaceuticals Inc. (stock ticker symbol CADX).
Also see all insider trading activities at Cadence Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | CADX | 0 | $0 | 85,343 | $660,059 | 85,343 | $299,553 |
2011 | CADX | 2,000 | $14,430 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-12-02 | CADX | Sale | 7,812 | 9.16 | 71,557 |
2013-12-02 | CADX | Option Ex | 7,812 | 3.51 | 27,420 |
2013-11-15 | CADX | Sale | 10,416 | 8.00 | 83,328 |
2013-11-15 | CADX | Option Ex | 10,416 | 3.51 | 36,560 |
2013-06-07 | CADX | Sale | 67,115 | 7.53 | 505,174 |
2013-06-07 | CADX | Option Ex | 67,115 | 3.51 | 235,573 |
2011-05-10 | CADX | Buy | 2,000 | 7.21 | 14,430 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Byrd Scott A. (SVP, Chief Commercial Officer of Cadence Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.